Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone ester, and other ketonic sources

Abstract

A composition comprising a dietary ketone, wherein the dietary ketone is designed to reduce migraine symptoms in a patient experiencing migraines and related method of manufacture and use are also disclosed.

Description

RELATED APPLICATIONS

[0001] This is a divisional of U.S. application Ser. No. 15 / 743,448 entitled “Prophylaxis and Mitigation of Migraine Headache Using Medium Chain Triglycerides Ketone Esters, and Other Ketogenic” filed on Jan. 10, 2018, which has now been granted a Notice of Allowance.FIELD OF THE INVENTION

[0002] The invention relates to migraine headaches, sometimes simply called migraine. More particularly, the invention relates to preventing, arresting, or reducing the frequency or severity of migraine.BACKGROUND OF THE INVENTION

[0003] Migraine is a neurological disease with a strong genetic component. It is characterized by episodes of disabling headache, often called migraine attacks. They are clinically quite different from regular headaches which are non-migrainous. There are about 100 million people with headaches in the U.S. and about 37 million of these people have migraines. The World Health Organization estimates that approximately 18 percent of Women and 7 percent of men...

Examples

Embodiment Construction

[0040]As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention.

[0041]The specific example below will enable the invention to be better understood. However, they are given merely by way of guidance and do not imply any limitation.

[0042]The invention relates to migraine headaches, sometimes simply called migraine. More particularly, the invention relates to preventing or reducing the frequency of migraine onset and reducing migraine symptoms. The invention provides effective, safer treatments to reduce frequency of migraine onset. The present inventors have surprisingly dis...

RELATED APPLICATIONS

[0001] This is a divisional of U.S. application Ser. No. 15 / 743,448 entitled “Prophylaxis and Mitigation of Migraine Headache Using Medium Chain Triglycerides Ketone Esters, and Other Ketogenic” filed on Jan. 10, 2018, which has now been granted a Notice of Allowance.FIELD OF THE INVENTION

[0002] The invention relates to migraine headaches, sometimes simply called migraine. More particularly, the invention relates to preventing, arresting, or reducing the frequency or severity of migraine.BACKGROUND OF THE INVENTION

[0003] Migraine is a neurological disease with a strong genetic component. It is characterized by episodes of disabling headache, often called migraine attacks. They are clinically quite different from regular headaches which are non-migrainous. There are about 100 million people with headaches in the U.S. and about 37 million of these people have migraines. The World Health Organization estimates that approximately 18 percent of Women and 7 percent of men...

Examples

Embodiment Construction

[0040]As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention that may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention.

[0041]The specific example below will enable the invention to be better understood. However, they are given merely by way of guidance and do not imply any limitation.

[0042]The invention relates to migraine headaches, sometimes simply called migraine. More particularly, the invention relates to preventing or reducing the frequency of migraine onset and reducing migraine symptoms. The invention provides effective, safer treatments to reduce frequency of migraine onset. The present inventors have surprisingly dis...